View in EDS

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.

Saved in:
Bibliographic Details
Title: Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.
Authors: Zakaria, Z, Tivnan, A1, Flanagan, L1, Murray, D W1, Salvucci, M1, Stringer, B W2, Day, B W2, Boyd, A W2, Kögel, D3, Rehm, M1, O'Brien, D F4, Byrne, A T1, Prehn, J H M1, Kögel, D3 (AUTHOR)
Source: British Journal of Cancer. 1/19/2016, Vol. 114 Issue 2, p188-198. 11p. 1 Diagram, 5 Graphs.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/bjc.2015.420